Skip to main content

Peer Review reports

From: Food and Drug Administration approvals in phase 3 Cancer clinical trials

Original Submission
6 Mar 2021 Submitted Original manuscript
23 Apr 2021 Reviewed Reviewer Report - Akihiko Shimomura
4 May 2021 Reviewed Reviewer Report
22 May 2021 Author responded Author comments - Cullen M. Taniguchi
Resubmission - Version 2
22 May 2021 Submitted Manuscript version 2
Publishing
27 May 2021 Editorially accepted
12 Jun 2021 Article published 10.1186/s12885-021-08457-5

You can find further information about peer review here.

Back to article page